![Logo MCSA [logo]](/templates/chamber/images/logo.svg){kind=logo}
Industry performance against targets: 2020 to 2022
| Activity | Milestone | 2020 | 2021 | 2022 | |
| Compliance to reporting | Companies on the system | 110 | 115 | 118 | |
| Completeness of reporting | >10% | 75 | 78 | 81 | |
| 11-50% | 1 | 1 | 1 | ||
| 60-99% | 1 | 3 | 4 | ||
| 100% | 30 | 33 | 32 | ||
| HIV counselling, testing and ART treatment | HIV counselling | 67.3% | 67.1% | 83.4% | |
| Annual HIV test (100%) | 43% | 49% | 53% | ||
| ART Treatment | 56.2% | 46.4% | 36.8% | ||
| TB screening | Annual TB screening (100%) | 68% | 75.4% | 83% | |
| TB incidence | Below the national TB incidence rate 5% year on year reduction for the TB incidence rate |
195 per 100 000 population |
221 per 100 000 population |
241 per 100 000 population |
|
| NCDs | Employees screened for hypertension (100%) | 67% | 74% | 84% | |
| Employees screened for diabetes (100%) | 59% | 59% | 80% | ||